Axios on MSN

How Eli Lilly became the new king of GLP-1s

Eli Lilly is poised to leapfrog Novo Nordisk and become the dominant player in an anti-obesity drug market that could reach ...
New Atlas

First oral GLP-1 cuts cardiovascular risk by 14% – and it's now FDA-approved

The age of the GLP-1 drug has reached yet another milestone, with the US Food and Drug Administration green-lighting Novo Nordisk's once-daily oral semaglutide pill to treat people at high risk of ...
Associated Press

Government shutdown to begin after midnight, mass furloughs of federal workers expected

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. The U.S. Capitol is photographed after a news ...
STAT

Lilly CSO defends hiring of ex-FDA chief Peter Marks

Morning, all. Today, we have more interesting tidbits from the STAT Summit: Eli Lilly’s CSO defends the company’s hiring of ...
National Academies of Sciences%2c Engineering%2c and Medicine

National Academies Publish New Report Reviewing Evidence for Greenhouse Gas Emissions and U.S. Climate, Health, and Welfare

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...

Lilly's weight-loss pill shows better blood sugar control in late-stage trials

Eli Lilly's experimental weight-loss pill showed superior blood sugar control in diabetic patients across two late-stage trials, the company said on Wednesday, as it seeks to widen its lead in the ...